The 20 Best Autosomal Dominant Hypocalcemia Doctors Near Me in Towson, MD

Craig Haber is an Endocrinologist in Towson, Maryland. Dr. Haber is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Cancer, and Anaplastic Thyroid Cancer.

Vivian Pao is an Endocrinologist in Towson, Maryland. Dr. Pao is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Storm, Osteoporosis, Postmenopausal Osteoporosis, and Congenital Adrenal Hyperplasia (CAH).

Kenneth Lindyberg is a General Surgeon in Towson, Maryland. Dr. Lindyberg is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Osteomyelitis, Peripheral Artery Disease, Arterial Insufficiency, and Obesity in Children.

Franco Vallejo is an Endocrinologist in Parkville, Maryland. Dr. Vallejo has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Protein Deficiency, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Autosomal Dominant Hypocalcemia.

Pamela Schroeder is an Endocrinologist in Baltimore, Maryland. Dr. Schroeder is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Nodule, Type 2 Diabetes (T2D), Osteoporosis, Maturity Onset Diabetes of the Young, and Endoscopy.

Isabel Bonilla is an Endocrinologist in Baltimore, Maryland. Dr. Bonilla is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Storm, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Graves Disease.

Malek Cheikh is an Endocrinologist in Baltimore, Maryland. Dr. Cheikh is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Joselito Cabacar is a Nephrologist in Baltimore, Maryland. Dr. Cabacar is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Igor Voronetsky is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Voronetsky is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Tonsillitis, Torticollis, Acute Cystitis, and Hospital-Acquired Pneumonia.

Maw Oo is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Oo has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Acute Kidney Failure, Sepsis, Hospital-Acquired Pneumonia, Endoscopy, and Colonoscopy.

Jacob Levine is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Anorexia, Retinopathy Arteriosclerotic, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Elizabeth Hamilton is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Hamilton is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Obesity, Maturity Onset Diabetes of the Young, Obesity in Children, and Lewy Body Dementia (LBD).

Sadia Baqai is a primary care provider, practicing in Geriatrics in Towson, Maryland. Dr. Baqai is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Maturity Onset Diabetes of the Young.

Kaleem Haque is a Nephrologist in Baltimore, Maryland. Dr. Haque is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, IgA Nephropathy, and Acute Kidney Failure.

David Da Rocha Afodu is a Nephrologist in Timonium, Maryland. Dr. Da Rocha Afodu is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, High Potassium Level, and Low Sodium Level. Dr. Da Rocha Afodu is currently accepting new patients.

Robert Stoltz is a primary care provider, practicing in Internal Medicine in Lutherville Timonium, Maryland. Dr. Stoltz has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Autosomal Dominant Hypocalcemia, Glossitis, Pernicious Anemia, and Vitamin B12 Deficiency.

Ibikunle Koya is a Nephrologist in Lutherville Timonium, Maryland. Dr. Koya is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Acute Kidney Failure.